Change to Covid vaccine formulation signals start of FDA pivot in immunization strategy

Recent evidence suggests that the current bivalent provides protection against severe disease and death from the XBB.1 variant that is dominant in the U.S. right now. “As we’ve turned the corner from a pandemic phase to an endemic phase,” said Ofer Levy, staff physician at Boston Children’s…

#xbb1 #oferlevy #harvardmedicalschool #fda #cdc #advisers #henrybernstein #hofstrauniversity #jerryweir